Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study.
Dapavo P, Siliquini N, Mastorino L, Avallone G, Merli M, Agostini A, Cariti C, Viola R, Stroppiana E, Verrone A, Ortoncelli M, Quaglino P, Ribero S. Dapavo P, et al. Among authors: verrone a. J Dermatolog Treat. 2022 Jun;33(4):2352-2357. doi: 10.1080/09546634.2021.1961998. Epub 2021 Aug 13. J Dermatolog Treat. 2022. PMID: 34315331
Multiple primary melanomas: analysis of 49 cases.
Savoia P, Quaglino P, Verrone A, Bernengo MG. Savoia P, et al. Among authors: verrone a. Melanoma Res. 1998 Aug;8(4):361-6. doi: 10.1097/00008390-199808000-00010. Melanoma Res. 1998. PMID: 9764812 Review.
Gender differences in genital lichen sclerosus: data from a multicenter Italian study on 729 consecutive cases.
Virgili A, Borghi A, Cazzaniga S, Di Landro A, Naldi L, Minghetti S, Fierro MT, Verrone A, Caproni M, Micali G, Gaspari V, Papini M, Di Lernia V, Germi L, Girolomoni G, Belloni Fortina A, Cannavò SP, Bilenchi R, Corazza M; GLS Italian Study Group. Virgili A, et al. Among authors: verrone a. G Ital Dermatol Venereol. 2020 Apr;155(2):155-160. doi: 10.23736/S0392-0488.17.05819-9. Epub 2018 Jan 24. G Ital Dermatol Venereol. 2020. PMID: 29368855 Free article.
Efficacy of switching from adalimumab originator to adalimumab biosimilar in moderate to severe psoriasis patients: A Real-life experience in a tertiary referral centre.
Gallo G, Rostagno E, Siliquini N, Stroppiana E, Verrone A, Ortoncelli M, Quaglino P, Dapavo P, Ribero S. Gallo G, et al. Among authors: verrone a. Australas J Dermatol. 2021 Aug;62(3):e431-e432. doi: 10.1111/ajd.13632. Epub 2021 May 27. Australas J Dermatol. 2021. PMID: 34042171 No abstract available.
Comparison of Secukinumab and Ixekizumab in psoriasis: a real-life cohort study on the efficacy and drug survival of 445 patients.
Cariti C, Dapavo P, Mastorino L, Ortoncelli M, Siliquini N, Merli M, Avallone G, Giordano S, Fabrizio R, Susca S, Verrone A, Stroppiana E, Quaglino P, Ribero S. Cariti C, et al. Among authors: verrone a. J Eur Acad Dermatol Venereol. 2022 Mar;36(3):e233-e235. doi: 10.1111/jdv.17766. Epub 2021 Nov 7. J Eur Acad Dermatol Venereol. 2022. PMID: 34672026 No abstract available.
38 results